📣 Cell Line Development on the Beacon Discovery Is Now Available
Explore Now

All Resources
App Note
Harnessing the Beacon Optofluidic Platform for Streamlined Discovery of Internalizing Antibodies

Bruker’s advanced optofluidic system enables efficient high-throughput functional screening of single antibody producing cells, leveraging live reporter cells to rapidly identify internalizing antibodies and accelerate antibody discovery and development.

What's Inside

In this App Note we discuss:

A feasibility study for screening internalizing antibodies using Bruker Cellular Analysis’s optofluidic instruments
Design of a live-cell in-channel assay tailored for the evaluation of receptor-targeted antibody internalization
Row rect Shape Decorative svg added to top
Get the App Note
Back to the Top